These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 371804)

  • 21. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of VP-16-213 in non-small-cell lung cancer.
    Itri LM; Gralla RJ; Chapman RA; Kelsen DP; Casper ES; Golbey RB
    Am J Clin Oncol; 1982 Feb; 5(1):45-7. PubMed ID: 7081137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 24. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
    Eagan RT; Ingle JN; Frytak S; Rubin J; Kvols LK; Carr DT; Coles DT; O'Fallon JR
    Cancer Treat Rep; 1977 Oct; 61(7):1339-45. PubMed ID: 589599
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.
    Eagan RT; Creagan ET; Bisel HF; Layton DD; Groover RV; Herman RC
    Oncology; 1981; 38(1):4-6. PubMed ID: 7443176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB; Blessing JA; Homesley HD; Currie JL; Yordan EL
    Invest New Drugs; 1984; 2(3):331-3. PubMed ID: 6511240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
    Suzuki K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose etoposide (VP-16) in small-cell lung cancer.
    Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of VM-26 as a single agent in the treatment of renal carcinoma.
    Hire EA; Samson MK; Fraile RJ; Baker LH
    Cancer Clin Trials; 1979; 2(4):293-5. PubMed ID: 394865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
    Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
    Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
    [No Abstract]   [Full Text] [Related]  

  • 35. Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
    Mulder NH; Meinesz AF; Sleijfer DT; Postmus PE; De Vries EG; Van der Geest S; Orie JL; Vriesendorp R
    Neth J Med; 1984; 27(10):389-92. PubMed ID: 6096742
    [No Abstract]   [Full Text] [Related]  

  • 36. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y; Ohshima S; Kado M; Nakayama M; Shimokata K; Sakai S; Ito F; Chikata E; Hara K; Kanda T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K; Murayama T; Sayama T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
    Muss HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Stuart JJ; Richards F
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):55-61. PubMed ID: 3883503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.